Cancer Risk Assessment: Examining the Family Physician’s Role

References

1. ↵
   Eberl MM, Sunga AY, Farrell CD, Mahoney MC. Patients with a family history of cancer: identification and management. J Am Board Fam Pract 2005; 18: 211–7.

   OpenUrlPubMed
2. ↵
   Sifri R, Gangadharappa S, Acheson L. Identifying and testing for hereditary susceptibility to common cancers. CA Cancer J Clin 2004; 54: 309–26.

   OpenUrlCrossRefPubMed
3. ↵
   Medalie JH, Zyzanski SJ, Langa D, Stange KC. The family in family practice: is it a reality? J Fam Pract 1998; 46: 390–6.

   OpenUrlPubMedWeb of Science
4. ↵
   Sifri RA, Wender R, Paynter N. Cancer risk assessment from family history: gaps in primary care practice. J Fam Pract 2002; 51: 856.

   OpenUrlPubMed
5. ↵
   Hampel H, Sweet K, Westman JA, Offit K, Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004; 41: 81–91.

   OpenUrlAbstract/FREE Full Text
6. ↵
   Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 2003; 124: 544–60.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   Pinsky PF, Kramer BS, Reding D, Buys S. Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol 2003; 157: 792–9.

   OpenUrlAbstract/FREE Full Text
8. ↵
   Strahm B, Malkin D. Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer 2006; Epub ahead of print: April 26.
9. ↵
   Acheson LS, Wiesner GL, Zyzanski S, Goodwin MA, Stange KS. Family history-taking in community practice: implications for genetic screening. Genet Med 2000; 2: 180–5.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Dove-Edwin I, Sasieni P, Adams J, Thomas J. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year prospective, follow-up study. BMJ 2005; 331: 1047. Epub 2005 Oct 21.

    OpenUrlAbstract/FREE Full Text
11. ↵
    Gennarelli M, Jandorf L, Cromwell C, Valdimarsdottir H, Redd W, Iskaowitz S. Barriers to colorectal cancer screening: inadequate knowledge by physicians. Mt Sinai J Med 2005; 72: 36–44.

    OpenUrlPubMed
12. ↵
    Schrony PC, Barriron AF, Ling BS, Wilson S, Geller AC. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 2002; 97: 1031–6.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health 1995; 85: 795–800.

    OpenUrlPubMedWeb of Science
14. ↵
    Tinley ST, Houfek J, Watson P, et al. Screening adherence in BRCA1/2 families is associated with primary physicians’ behavior. Am J Med Genet A 2004; 125: 5–11.

    OpenUrl
15. ↵
    Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med 2003; 115: 129–33.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 2004; 141: 264–71.

    OpenUrlPubMedWeb of Science
17. ↵
    Bampton PA, Sandford JJ, Young GP. Applying evidence-based guidelines improves use of colonoscopy resources in patients with a moderate risk of colorectal neoplasia. Med J Aust 2002; 176: 155–7.

    OpenUrlPubMed
18. ↵
    Paskett ED, Tatum C, Rushing J, et al. Racial differences in knowledge, attitudes, and cancer screening practices among a triracial rural population. Cancer 2004; 101: 2650–9.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Hall M, Olopade O. Confronting genetic testing disparities: knowledge is power. JAMA 2005; 293: 1783–5.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005; 41: 23–9.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 2005; 293: 1729–36.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    Clayton EW. Ethical, legal, and social implications of genomic medicine. N Engl J Med 2003; 349: 562–9.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    Gramling R, Nash J, Siren K, Eaten C, Culpepper L. Family physician self-efficacy with screening for inherited cancer risk. Ann Fam Med 2004; 2: 130–2.

    OpenUrlAbstract/FREE Full Text
24. ↵
    Severin MJ. Genetic susceptibility for specific cancers: medical liability of the clinician. Cancer 1999; 86: 1744–9.

    OpenUrlCrossRef
25. ↵
    Sweet K, Willis SK, Ashida S, Westman JA. Use of fear-appeal techniques in the design of tailored cancer risk communication messages: implications for healthcare providers. J Clin Oncol 2003; 21: 3375–6.

    OpenUrlFREE Full Text
26. ↵
    Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst 1999; 25: 59–66.

    OpenUrl
27. ↵
    Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 23: 22–30.

    OpenUrl
28. ↵
    Kinney AY, DeVellis BM, Skrzynia C, Millikan R. Genetic testing for colorectal carcinoma susceptibility. Cancer 2001; 91: 57–65.

    OpenUrlPubMed
29. ↵
    McInerney-Leo A, Biesecker BB, Hadley DW, et al. BRCA1/2 testing in hereditary breast and ovarian cancer families. II: Impact on relationships. Am J Med Genet A 2005; 133: 165–9.

    OpenUrl
30. ↵
    Madlensky L, Esplen MJ, Gallinger S, et al. Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med 2003; 25: 187–94.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    Edwards A, Unigwe S, Elwyn G, Hood K. Effects of communicating individual risks in screening programmes: Cochrane systematic review. BMJ 2003; 327: 703–9.

    OpenUrlAbstract/FREE Full Text
32. ↵
    Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin 2004; 54: 150–80.

    OpenUrlCrossRefPubMedWeb of Science